CDR Short Squeeze Failure?
This is an update to: 
As noted before we lacked upward movement that could end 2nd elliott wave in a statistically popular fibo retracement level. As short squeeze against Mevlin Capital inspired detail investors we have reached a popular level of 61.8%. It seems that memes have lost their momentum for buying stocks like GME or AMC according to what can be seen on the charts I assume the same will happen CDR. Just as writing this possibly S&P500 and NDX stocks are starting to loose upward momentum for the day tomorrow might be a crucial day for CDR. Reaching MA200 cannot come unnoted.
New Fundamentals (previous are still in effect):
Polish WIG20 index which CDR is part of has reached a significant barrier where bears can return.
New Speculation (previous are still in effect):
Short squeeze against Melin Capital (still shorting CDR but at significantly lower level) is loosing momentum as panic movements can be observed both on GME and AMC.
As noted before we lacked upward movement that could end 2nd elliott wave in a statistically popular fibo retracement level. As short squeeze against Mevlin Capital inspired detail investors we have reached a popular level of 61.8%. It seems that memes have lost their momentum for buying stocks like GME or AMC according to what can be seen on the charts I assume the same will happen CDR. Just as writing this possibly S&P500 and NDX stocks are starting to loose upward momentum for the day tomorrow might be a crucial day for CDR. Reaching MA200 cannot come unnoted.
New Fundamentals (previous are still in effect):
Polish WIG20 index which CDR is part of has reached a significant barrier where bears can return.
New Speculation (previous are still in effect):
Short squeeze against Melin Capital (still shorting CDR but at significantly lower level) is loosing momentum as panic movements can be observed both on GME and AMC.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.